Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

25.72
BATS BZX Real-Time Price
As of 1:21pm ET
 -0.29 / -1.11%
Today’s Change
25.56
Today|||52-Week Range
35.04
-24.24%
Year-to-Date
Top Research Reports for Cisco, Merck & MasterCard
1:02pm / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
Why AstraZeneca plc Stock Slumped in November
10:33am / MotleyFool.com - Paid Partner Content
3 Horrible Stocks for Retirees
Nov 30 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
10:02am / Zacks.com - Paid Partner Content
Biotech Stock Mailbag: Looking for an Investable Idea in Alzheimer's Mine Field
Nov 30 / TheStreet.com - Paid Partner Content
8 Uncommon Stocks NWQ Managers Is Buying
Dec 06 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALI...
Nov 28 / Zacks.com - Paid Partner Content
Frontrunning: December 5
Dec 05 / Investing Channel - Paid Partner Content
Eli Lilly Hits 52-Week Low on Poor Data on Alzheimer's Drug
Nov 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close26.01
Today’s open26.21
Day’s range25.56 - 26.21
Volume440,280
Average volume (3 months)5,939,265
Market cap$65.3B
Dividend yield5.44%
Data as of 1:21pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+128.05%
Earnings growth (this year)-1.08%
Earnings growth (next 5 years)-1.20%
Revenue growth (last year)-5.11%
P/E ratio26.5
Price/Sales3.48
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.19-0.54%
AGNAllergan-1.34-0.70%
ABTAbbott Laboratories-0.21-0.55%
LLYEli Lilly and Co-0.71-1.05%
Data as of 1:21pm ET, 12/07/2016

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.60
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London

Forecasts


Search for Jobs